Bibb Instruments Launches Endodrill GI Biopsy System in US with Taewoong
Photo by National Cancer Institute on Unsplash
Bibb Instruments has commercially launched its Endodrill GI biopsy instrument in the U.S. through a distribution partnership with Taewoong Medical USA, who have already made sales to several hospitals. Bibb Instruments' CEO called receiving the first commercial order a "significant milestone" for the company, describing Endodrill as the first market-approved, electric-powered biopsy system designed for endoscopic procedures.
Key takeaways
- According to Medtech Magazine, Bibb Instruments has commercially launched its Endodrill GI biopsy instrument in the United States through a distribution partnership with Taewoong Medical USA
- Bibb Instruments describes the Endodrill as the first market-approved, electric-powered biopsy system designed for endoscopic procedures
- Taewoong Medical USA has already completed initial sales to several hospitals
Related Topics
Want coverage like this for your company?
Local & industry wins build trusted proof, SEO/geo signals and prime national editors.
Verified mention available
Is this your company?
Set up real-time alerts and keep your Heartspace News coverage accurate. Verified teams can update profiles, request corrections, and collaborate on future stories.
Want to turn mentions into momentum? Find your best path with the Fit Checker. Verified profiles receive a free consult.